Evaluation of Pharmacist-guided Digital-based Asthma Education for Indonesian Children With Asthma
MIRACLE
1 other identifier
interventional
50
1 country
4
Brief Summary
Poor adherence and self-management in children with asthma results in poorly controlled asthma and increased morbidity. Pharmacists could take important roles in delivering asthma education to ensure that children can manage their disease. This study aims to evaluate the effectiveness of improving asthma control, knowledge, and quality of life. An open, randomized controlled trial will be conducted to evaluate the effectiveness of pharmacist-led digital-based asthma self-management education for children with asthma compared with paper-based asthma self-management education. Recruitment of the participants will be held at the outpatient ward of the Department of Paediatrics in 4 public hospitals in Bali Province, Indonesia, including Sanglah Public Hospital, Denpasar City; Wangaya Public Hospital, Denpasar City; Mangusada Public Hospital, Badung Regency; and Udayana University Hospital, Badung Regency. Participants will be provided with informed consent, then randomly divided into either a control group or an intervention group. The following will be the hypotheses of the study:
- 1.The intervention group receiving the MIRACLE education program has a better asthma control compared to the control group.
- 2.The intervention group receiving the MIRACLE education program has a greater improvement in asthma quality of life compared to the control group.
- 3.The intervention group receiving the MIRACLE education program has a better understanding of asthma knowledge in general compared to the control group.
- 4.The intervention group receiving the MIRACLE education program has a better performance in practicing inhaler techniques compared to the control group.
- 5.The intervention group receiving the MIRACLE education program has fewer unscheduled visits to the hospital and less hospitalization compared to the control group.
- 6.The intervention group receiving the MIRACLE education program will be satisfied with the digital asthma education.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Aug 2022
Shorter than P25 for not_applicable
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 16, 2022
CompletedFirst Posted
Study publicly available on registry
June 27, 2022
CompletedStudy Start
First participant enrolled
August 20, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 31, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2022
CompletedJune 27, 2022
June 1, 2022
2 months
June 16, 2022
June 20, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Asthma Control as assessed by Asthma Control Questionnaire (ACQ).
The primary outcome will be the changes in asthma control. The Indonesian version of the Asthma Control Questionnaire (ACQ, proposed by Juniper et al, 1995) is a validated measure of a patient's abilities to control asthma. It composes of 5 questions about asthma symptoms, 1 question about bronchodilator use during the previous week, and 1 question about FEV1% change. All questions will be scored 0 to 6, and a total score will be expressed as the mean of these scores. Asthma control will deteriorate as the score increase. A clinically important change in ACQ score will be reported to be 0.5. If the post-test score will be lower than the pretest score, it will be indicated that asthma control will be improved. Patients will be asked to recall their experiences during the previous 7 days and will respond to the questions using a 7-point scale.
2 months
Secondary Outcomes (7)
Asthma Quality of Life assessed by Pediatric Asthma Quality of Life Questionnaire (PAQLQ)
2 months
The level of asthma knowledge, assessed by Asthma Knowledge Questions
2 months
Number of Correct Inhaler Techniques Performance, assessed by Indonesian Inhaler Practice Checklist
2 months
number of unscheduled visits
2 months
number of hospitalization
2 months
- +2 more secondary outcomes
Study Arms (2)
Intervention group (the digital asthma education program)
EXPERIMENTALThe intervention group receives the digital asthma education program (MIRACLE program). It consists of an asthma interactive narrative, a serious game, and an asthma action plan. It mainly covers asthma self-management and asthma attack prevention, such as asthma definition, asthma triggers and how to prevent asthma triggers exposures, asthma medications, proper inhaler technique, and asthma written action plan. The time schedule will be described as: 1. Explain study purposes, program, procedures, and instructions (10 minutes). 2. Accompany children and parents to download and install the MIRACLE program on Google Play Store for free on their personal computers, tablets, or smartphones (5 minutes). 3. Asthma education will take place over one session lasting approximately 45 minutes.
Control group (the booklet asthma education program)
ACTIVE COMPARATORFor the control group, a pharmacist (same personnel) will provide an asthma education using a booklet for 45-60 minutes to children and parents. Patients will be asked to read the booklet at home for 15 minutes in 7 days. It mainly covered the same content as the MIRACLE program. The time schedule will be described as: 1. Explain study purposes, booklet, procedures, and instructions (10 minutes). 2. Asthma education will take place over one session lasting approximately 45 minutes.
Interventions
The intervention group receives the digital asthma education program (MIRACLE program). It consists of an asthma interactive narrative, a serious game, and an asthma action plan. It mainly covers asthma self-management and asthma attack prevention, such as asthma definition, asthma triggers and how to prevent asthma triggers exposures, asthma medications, proper inhaler technique, and asthma written action plan.
Eligibility Criteria
You may qualify if:
- Children with asthma, asthma was diagnosed by a medical doctor, pediatrician, or medical records.
- Children with asthma in the range age of 6 - 13 years old.
- Had a history of asthma or had a previous asthma attack in 1 year.
- Able to communicate in Bahasa Indonesia and pose to use a computer, tablet, or smartphone.
- No serious cognitive impairments.
- Agree to participate in the study and follow the instructions.
You may not qualify if:
- Disagree to participate in the study.
- Had another history of respiratory diseases or conditions that may affect responses.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (4)
Mangusada Teaching Hospital
Badung, Bali, 80116, Indonesia
Udayana University Hospital
Badung, Bali, 80116, Indonesia
Sanglah General Hospital
Denpasar, Bali, 80234, Indonesia
Wangaya Teaching Hospital
Denpasar, Bali, 80234, Indonesia
Related Publications (1)
Sarasmita MA, Larasanty LPF, Kuo LN, Cheng KJ, Chen HY. A Computer-Based Interactive Narrative and a Serious Game for Children With Asthma: Development and Content Validity Analysis. J Med Internet Res. 2021 Sep 13;23(9):e28796. doi: 10.2196/28796.
PMID: 34515641BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Hsiang Yi Chen, Prof
Taipei Medical University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- The outcome assessors for collecting outcome data at 1 and 2 months will be masked to group allocation. They will also be prohibited to contact patients directly.
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Pharmacist, Department of Pharmacy, Faculty of Mathematics and Science, Udayana University; PhD student, Department of Clinical Pharmacy, Taipei Medical University, Taipei, Taiwan
Study Record Dates
First Submitted
June 16, 2022
First Posted
June 27, 2022
Study Start
August 20, 2022
Primary Completion
October 31, 2022
Study Completion
December 31, 2022
Last Updated
June 27, 2022
Record last verified: 2022-06
Data Sharing
- IPD Sharing
- Will not share